Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Howard L. Kaufman

51-100 of 104 results

View this query on the Wikidata Query Service
Treatment of pediatric ocular melanoma with high-dose interleukin-2 and thalidomide

scientific article
Cytokine therapy for cancer

scientific article published on 01 October 2007
Results of a randomized phase I gene therapy clinical trial of nononcolytic fowlpox viruses encoding T cell costimulatory molecules

scientific article
A Phase II Study of AT-101 to Overcome Bcl-2–Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer

scientific article published on September 21, 2015
Critical analysis of an oncolytic herpesvirus encoding granulocyte-macrophage colony stimulating factor for the treatment of malignant melanoma

scientific article
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.

scientific article published on 18 October 2016
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

scientific article published on 16 September 2014
Surgical treatment of stage IV melanoma.

scientific article published in May 2004
Small bowel obstruction by jejunal enterolith

scientific article published on 01 February 1997
HIV infection accelerates gastrointestinal tumor outgrowth in NSG-HuPBL mice

scientific article published on 3 April 2014
Two roads for oncolytic immunotherapy development

article
Leiomyoma of the breast

scientific article published on 01 May 1996
Unleashing the therapeutic potential of oncolytic viruses

scientific article published on 5 March 2018
Gene therapy for antitumor vaccination

scientific article
High-dose IL-2 induces rapid albumin uptake by endothelial cells through Src-dependent caveolae-mediated endocytosis

scientific article published on 25 June 2014
Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry

scientific article
Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells.

scientific article
Management of metastatic malignant melanoma of the bladder

scientific article published on 01 August 2003
Clinical protocol. Intra-Lesional rF-B7.1 versus rF-TRICOM vaccine in the treatment of metastatic cancer

Melanoma as a model for precision medicine in oncology

scientific article published on February 7, 2014
Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis

scientific article published on 21 August 2018
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)
Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer

scientific article published on 30 December 2019
Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

scientific article published on 10 August 2019
Initial clinical response predicts outcome and is associated with dose schedule in metastatic melanoma and renal cell carcinoma patients treated with high-dose interleukin 2

scientific article published on 04 April 2005
Surgical Management of Melanoma

scientific article
An update on TroVax for the treatment of progressive castration-resistant prostate cancer

scientific article
Avelumab and other recent advances in Merkel cell carcinoma

scientific article published on 4 October 2017
Oncolytic viruses: a new class of immunotherapy drugs

scientific article published on 01 August 2016
Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer

scientific article published on 01 January 2005
Multi-parametric flow cytometry staining procedure for analyzing tumor-infiltrating immune cells following oncolytic herpes simplex virus immunotherapy in intracranial glioblastoma

scientific article published on 04 April 2019
Overall survival of metastatic melanoma patients treated with HD IL-2 followed by immune checkpoint blockade of the CTLA-4 or the PD-1 pathways: analysis of data on the current use of HD IL-2.

scientific article published on 4 November 2015
Management of metastatic melanoma to the breast with high-dose interleukin-2 and surgical resection

scientific article published on 01 March 2005
Oncolytic Immunotherapy

scientific article published on 05 April 2019
Chemokines and cancer.

scientific article published on 01 January 2002
Combination Immunotherapy for Melanoma

scientific article published on 01 June 2015
Author Correction: Integrating oncolytic viruses in combination cancer immunotherapy

scientific article published on 01 August 2018
Combination immunotherapy with anti-CTLA-4 and interleukin-2 redirects regulatory T cells into tumor-draining lymph nodes and expands anti-tumor CD8+ T cells in the tumor microenvironment

scientific article published on 6 November 2014
Triple threat to cancer: rationale for combining oncolytic viruses, MEK inhibitors, and immune checkpoint blockade

scientific article published on 03 February 2019
High dose interleukin-2 registry, PROCLAIM™; higher center-specific IL-2 dose density correlates with higher response rates

scientific article published on 7 November 2013
Role of dose selection in successful interleukin-2 immunotherapy: solving the Goldilock’s Complex

scientific article published on 7 November 2013
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

scientific article published on 01 January 2019
Finding gold in tumour immunotherapy.

scientific article
The impact of age on a mitoxantrone-based tumor vaccine

scientific article published on 7 November 2013
The role of surgery following incomplete response to high-dose IL-2 (HD IL-2).

scientific article published on 7 November 2013
Durability of responses in patients with metastatic renal cell carcinoma treated with high dose interleukin-2 (HD IL-2).

scientific article published on 4 November 2015
Acute viral infection results in a PD-1-dependent loss of anti-tumor CD8+ T cell responses: implications for tumor immunotherapy

scientific article published on 4 November 2015
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016
Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma

scientific article published on 4 November 2015
Combination immunotherapy with Interleukin-2 and CTLA-4 blockade decreases tumor growth and improves overall survival

scientific article published on 7 November 2013

Paulina is supported by:

About Paulina

Help